Jonathan B. Wagner

495 total citations
24 papers, 215 citations indexed

About

Jonathan B. Wagner is a scholar working on Surgery, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Jonathan B. Wagner has authored 24 papers receiving a total of 215 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 10 papers in Pediatrics, Perinatology and Child Health and 5 papers in Oncology. Recurrent topics in Jonathan B. Wagner's work include Lipoproteins and Cardiovascular Health (9 papers), Pharmaceutical studies and practices (9 papers) and Drug Transport and Resistance Mechanisms (5 papers). Jonathan B. Wagner is often cited by papers focused on Lipoproteins and Cardiovascular Health (9 papers), Pharmaceutical studies and practices (9 papers) and Drug Transport and Resistance Mechanisms (5 papers). Jonathan B. Wagner collaborates with scholars based in United States, Canada and South Korea. Jonathan B. Wagner's co-authors include Susan M. Abdel‐Rahman, J. Steven Leeder, Andrea Gaedigk, Leon van Haandel, Roger Gaedigk, Geetha Raghuveer, Ralph E. Kauffman, Valentina Shakhnovich, Chelsea M. Hosey and Kevin Watt and has published in prestigious journals such as Medicine & Science in Sports & Exercise, Clinical Pharmacology & Therapeutics and Experimental Biology and Medicine.

In The Last Decade

Jonathan B. Wagner

22 papers receiving 210 citations

Peers

Jonathan B. Wagner
Lisa Hendricks United States
Ziran Li China
Jerry Herron United States
WY Kim South Korea
Camille Lenoir Switzerland
Cheng Leng Chan Singapore
Jonathan B. Wagner
Citations per year, relative to Jonathan B. Wagner Jonathan B. Wagner (= 1×) peers Thomas Stammschulte

Countries citing papers authored by Jonathan B. Wagner

Since Specialization
Citations

This map shows the geographic impact of Jonathan B. Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan B. Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan B. Wagner more than expected).

Fields of papers citing papers by Jonathan B. Wagner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan B. Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan B. Wagner. The network helps show where Jonathan B. Wagner may publish in the future.

Co-authorship network of co-authors of Jonathan B. Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan B. Wagner. A scholar is included among the top collaborators of Jonathan B. Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan B. Wagner. Jonathan B. Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Forsha, Daniel, et al.. (2023). Peak Oxygen Consumption (VO2peak) Recovery Delay in a Pediatric Fontan Population. Medicine & Science in Sports & Exercise. 55(11). 1961–1967. 1 indexed citations
3.
Wagner, Jonathan B., et al.. (2023). Examining Technologies Used in K-12 School Districts: A Proposed Framework for Classifying Educational Technologies. Journal of Educational Technology Systems. 51(3). 282–302. 4 indexed citations
5.
Ramsey, Laura B., Li Gong, Seung‐been Lee, et al.. (2022). PharmVar GeneFocus: SLCO1B1. Clinical Pharmacology & Therapeutics. 113(4). 782–793. 41 indexed citations
6.
Hosey, Chelsea M., Sherwin S. Chan, Iván L. Csanaky, et al.. (2021). Efficacy of Weight Reduction on Pediatric Nonalcoholic Fatty Liver Disease: Opportunities to Improve Treatment Outcomes Through Pharmacotherapy. Frontiers in Endocrinology. 12. 663351–663351. 10 indexed citations
7.
Chan, Sherwin S., et al.. (2021). Critical need for pharmacologic treatment options in NAFLD: A pediatric perspective. Clinical and Translational Science. 14(3). 781–783. 2 indexed citations
8.
Wagner, Jonathan B., et al.. (2020). Functional Consequences of Pravastatin Isomerization on OATP1B1-Mediated Transport. Drug Metabolism and Disposition. 48(11). 1192–1198. 7 indexed citations
9.
Wagner, Jonathan B., Susan M. Abdel‐Rahman, Andrea Gaedigk, et al.. (2020). Impact of SLCO1B1 Genetic Variation on Rosuvastatin Systemic Exposure in Pediatric Hypercholesterolemia. Clinical and Translational Science. 13(3). 628–637. 8 indexed citations
10.
Wagner, Jonathan B., et al.. (2019). Drug Dose Selection in Pediatric Obesity: Available Information for the Most Commonly Prescribed Drugs to Children. Pediatric Drugs. 21(5). 357–369. 18 indexed citations
11.
Ogungbenro, Kayode, Jonathan B. Wagner, Susan M. Abdel‐Rahman, J. Steven Leeder, & Aleksandra Galetin. (2019). A population pharmacokinetic model for simvastatin and its metabolites in children and adolescents. European Journal of Clinical Pharmacology. 75(9). 1227–1235. 4 indexed citations
12.
Wagner, Jonathan B.. (2019). Children Are Not Small Adults: Specific Findings in Statin Exposure and Response in a Growing Population. Clinical Pharmacology & Therapeutics. 106(2). 278–280. 5 indexed citations
13.
Mclaughlin, Matthew, et al.. (2018). Considerations for Implementing Precision Therapeutics for Children. Clinical and Translational Science. 12(2). 140–150. 11 indexed citations
14.
Wagner, Jonathan B., Susan M. Abdel‐Rahman, Roger Gaedigk, et al.. (2018). Impact of Genetic Variation on Pravastatin Systemic Exposure in Pediatric Hypercholesterolemia. Clinical Pharmacology & Therapeutics. 105(6). 1501–1512. 17 indexed citations
15.
Wagner, Jonathan B., et al.. (2017). A Rare Case of Vascular Ring and Coarctation of the Aorta in Association with CHARGE Syndrome. Texas Heart Institute Journal. 44(2). 138–140. 3 indexed citations
16.
Haandel, Leon van, et al.. (2016). Quantification of pravastatin acid, lactone and isomers in human plasma by UHPLC-MS/MS and its application to a pediatric pharmacokinetic study. Journal of Chromatography B. 1012-1013. 169–177. 8 indexed citations
17.
Wagner, Jonathan B. & Susan M. Abdel‐Rahman. (2013). Pediatric Pharmacokinetics. Pediatrics in Review. 34(6). 258–269. 15 indexed citations
18.
Tisma‐Dupanovic, Svjetlana, Jonathan B. Wagner, Sanket Shah, David T. Huang, & Arthur J. Moss. (2013). An Adolescent with Possible Arrhythmogenic Right Ventricular Dysplasia and Long QT Syndrome: Evaluation and Management. Annals of Noninvasive Electrocardiology. 18(1). 75–78. 1 indexed citations
19.
Wagner, Jonathan B. & J. Steven Leeder. (2012). Pediatric Pharmacogenomics. Pediatric Clinics of North America. 59(5). 1017–1037. 8 indexed citations
20.
Hayden, Rachel, Bill Garoutte, Jonathan B. Wagner, & Robert B. Aird. (1961). Binding of Radioactive Sodium, Potassium, and Bromide in Guinea Pig Brain Homogenates.. Experimental Biology and Medicine. 107(4). 754–760. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026